603087.SS
Gan & Lee Pharmaceuticals. [603087.SS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
603087.SS Stock Summary
Top 10 Correlated ETFs
603087.SS
Top 10 Correlated Stocks
603087.SS
In the News
603087.SS Financial details
Company Rating
-
Market Cap
25.85B
Income
240.77M
Revenue
2.38B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
4.06K
Optionable
No
Shortable
Yes
Earnings
25 Apr 2024
P/E
111.81
Forward P/E
-
PEG
-13.42
P/S
11.44
P/B
2.72
P/C
-
P/FCF
-41.58
Quick Ratio
6.45
Current Ratio
7.65
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.43
EPS next Y
-
EPS next Q
-
EPS this Y
-130.12%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-6.43%
Revenue Q/Q
0.62%
EPS Q/Q
60%
-
-
-
-
SMA20
1.53%
SMA50
-10.04%
SMA100
-2.82%
Inst Own
-
Inst Trans
-
ROA
2%
ROE
2%
ROC
0.02%
Gross Margin
74%
Oper. Margin
7%
Profit Margin
10%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
32.1-62.9
52W High
+3.42%
52W Low
+100.38%
RSI
53.66
Rel Volume
0.53
Avg Volume
10.98M
Volume
5.78M
Perf Week
0.19%
Perf Month
-2.55%
Perf Quarter
-11.07%
Perf Half Y
-15.24%
-
-
-
-
Beta
1.611
-
-
Volatility
0.79%, 2.21%
Prev Close
0.71%
Price
64.12
Change
0.19%
Company Profile
- Volume Average 10.98M
- Market Capitalization 25.85B
- Employee 4.06K
- CEO Mr. Gan Zhongru
- Headquarters Beijing,CN
- IPO Date 2020-06-29
-
Website
https://www.ganlee.com 
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
